Collaborative Care for Treatment of Depression and Anxiety

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKaiser Permanente

About this trial

The goal of this project is to evaluate the effectiveness of a collaborative care model for primary care patients at Kaiser Permanente Colorado (KPCO) with depression and/or anxiety. Collaborative care uses evidence-based short-term treatments delivered to patients over the phone. We will explore the use of cost-efficient automated processes for patient outreach and follow-up, such as care pools of patients and using patient portal messaging, risk-based results routing to providers, and electronic health record (EHR) tools for patient tracking and outcome assessment. Using a cluster randomized design, we will compare results between clinics that are offering collaborative care to those that are not.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18+

Current membership and active on patient portal

Depression Diagnosis in the prior year

High Risk: Last PHQ9 screener was completed greater than 4 months ago AND total Score is greater than or equal 10 or item 9 is greater than 0.

Disqualifiers

Psychosis

Dementia

Bipolar

Personality Disorders

Trial population

Patients with depression and/or anxiety.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Collaborative Care

    Behavioral

    Collaborative care components include patient-centered team care, population-based care, measurement-based treatment to target, evidence-based care, and accountable care.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: Collaborative Care offered1 intervention
Group B: No Collaborative Care offered0 interventions

Trial outcomes

Primary outcomes

1

Patient Health Questionnaire 9-item (PHQ-9) score

Change in Patient Health Questionnaire 9-item (PHQ-9) scores before and after Collaborative Care intervention. The score ranges from 0 to 27, with lower numbers indicating improvement in depression symptoms.

Time frame
Baseline and up to 24 weeks
2

Generalized Anxiety Disorder 7-item (GAD-7)

Generalized Anxiety Disorder 7-item (GAD-7) questionnaire scores before and after Collaborative Care intervention. The score ranges from 0 to 21, with lower numbers indicating improvement in anxiety symptoms.

Time frame
Baseline and up to 24 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Kaiser Permanente

Lead sponsor

Garfield Memorial Fund

Collaborator